Motion artifact reduction on parametric PET images of neuroreceptor binding

Journal of Nuclear Medicine

Volumn 46, Issue 6, 2005, Pages 1059-1065

  Herzog, Hans ^a,b   Tellmann, Lutz ^a,b   Fulton, Roger ^c,d   Stangier, Isabelle ^a   Kops, Elena Rota ^a,b   Bente, Kay ^a,e   Boy, Christian ^a,b   Hurlemann, Rene ^b,f   Pietrzyk, Uwe ^a,b,e  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b Brain Imaging Center West   (Germany)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF WUPPERTAL   (Germany)

^f UNIVERSITY OF BONN   (Germany)

Author keywords

Graphic analysis; Head motion correction; Neuroreceptor PET

Indexed keywords

ALTANSER F 18; RADIOPHARMACEUTICAL AGENT; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; ALTANSERIN; DRUG DERIVATIVE; FLUORINE; KETANSERIN;

ARTICLE; ARTIFACT; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG RECEPTOR BINDING; GRAY MATTER; HEAD MOVEMENT; HEAD POSITION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER; BRAIN; IMAGE PROCESSING; METABOLISM; SCINTISCANNING;

ARTIFACTS; BRAIN; FLUORINE RADIOISOTOPES; HEAD MOVEMENTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KETANSERIN; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 23044510996     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kemna L, Posse S, Tellmann L, Schmitz T, Herzog H. Interdependence of regional and global cerebral blood flow during visual stimulation: an O-15 butanol positron emission tomography study. J Cereb Blood Flow Metab. 2001;21:664-670.
2. Thornton AF, Ten Haken RK, Weeks KJ, Gerhardsson A, Correll M, Lash KA. A head immobilization system from radiation simulation, CT, MRI, and PET imaging. Med Dosim. 1991;16:51-56.
3. Bergstrom M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comuit Assist Tomogr. 1981;5:136-141.
4. Anderson JL, Vagnhammar BE, Schneider H. Accurate attenuation correction despite movement during PET imaging. J Nucl Med. 1995;36:670-678.
5. Picard Y, Thompson CJ. Motion correction of PET images using multiple acquisition frames. IEEE Trans Med Imaging 1997;16:137-144.
6. Anderson JL. How to obtain high-accuracy image registration: application to movement correction of dynamic positron emission tomography data. Eur J Nucl Med 1998;25:575-586.
7. Fulton RR, Meikle SR, Eberl S, Pfeiffer J, Constable C, Fulham MJ. Correction for head movements in positron emission tomography using an optical motion tracking system. IEEE Trans Nucl Sci. 2002;49:116-123.
8. Bloomfield PM, Spinks TJ, Reed J, et al. The design and implementation of a motion correction scheme for neurological PET. Phys Med Biol. 2003;48:959-978.
9. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
10. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
11. Slifstein M, Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med 2000;41:2083-2088.
12. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
13. Hurlemann R, Boy C, Scherk H, et al. Decreased serotonin2A receptor binding in prodromal phases of schizophrenia [abstract]. Neuroimage. 2004;22(suppl 1):35(TU174 CD-ROM).
14. Tellmann L, Fulton RR, Bente K, et al. Motion correction of head movements in PET: realisation for routine usage. IEEE Nuclear Science Symposium Conference Record. 2003;5:3105-3107.
15. Zubal G, Harrell CR, Smith EO, Rattner Z, Gindi G, Hoffer PE. Computerized three-dimensional segmented human anatomy. Med Phys. 1994;21:299-302.
16. Price JC, Lopresti BJ, Meltzer CC, et al. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. Synapse 2001;41:11-21.
17. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096-1112.
18. Burger C, Buck A. Requirements and implementation of a flexible kinetic modeling tool. J Nucl Med 1997;38:1818-1823.
19. Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. J Cereb Blood Flow Metab. 2001;21:307-320.
20. Ichise M, Toyama H, Innis RB, Carson R. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271-1281.
21. Buchert R, Wilke F, van den Hoff J, Mester J. Improved statistical power of the multilinear reference tissue approach to the quantification of neuroreceptor ligand binding by regularization. J Cereb Blood Flow Metab. 2003;23:612-620.
22. Fulton RR, Nickel I, Tellmann L, Meikle SR, Pietrzyk U, Herzog H. Event-by-event motion compensation in 3D PET. IEEE Nuclear Science Symposium Conference Record. 2003;5:3286-3285.
23. Buehler P, Just U, Will E, Kotzerke J, van den Hoff J. An accurate method for correction of head movement in PET. IEEE Trans Med imaging. 2004;23:1176-1185.